MEMPHASYS LIMITED. — Board/Management Information 2016

Aug 29, 2016

==> picture [222 x 64] intentionally omitted <==

ASX Release Sydney, Australia Tuesday 30 August 2016

Appointment of Independent, Non-executive Director

Memphasys Limited is pleased to announce that it has appointed Mr. John Pereira as an independent, non-executive director, effective today.

Mr. Pereira, B.Juris, LLB. (Bond University) has had an extensive professional career encompassing funds management, banking and law.

Mr. Pereira’s early career was in banking and finance in Australia where he was an early developer of financial products for the funds management industry. Mr. Pereira jointly established Norbury Pereira Lawyers, a boutique commercial legal practice, and subsequently formed a partnership with Cornwall Stodart Lawyers where he became the Deputy Managing Partner.

Mr. Pereira was Head of Corporate Advisory for Burdett Buckeridge Young in 2000. Subsequently, Mr. Pereira formed Alchemy Corporate Advisors Pty Ltd with Burdett Buckeridge Young to promote corporate advisory and capital raising for small/mid cap clients. In 2004 Mr. Pereira established Tristar Corporate Advisors Pty Ltd providing corporate advice to a range of private and ASX listed companies and he continues to advise a number of small and mid-cap companies.

Mr. Pereira was the founder and CEO of India Equities Fund Limited which listed on ASX in 2007. He also created Olympus Funds Management to offer a wide range of investment opportunities in alternative investment markets.

Mr. Pereira has maintained a close interest in India, his country of birth, and is a former President (Victoria) and Deputy Chairman of the Australia India Business Council.

Alongside Mr. Pereira’s commercial activities, he has been admitted to the Supreme Courts of NSW and Victoria and has held a legal practising certificate for over 20 years.

The Board welcomes Mr. Pereira to the Company.

For further information please contact:

Alison Coutts Executive Chairman +61 2 8415 7300 alison.coutts@memphasys.com

About Memphasys:

Memphasys Limited ( ASX: MEM ) specialises in biological separations for commercial applications. The Company’s patented membrane processes enable the selection of high value substances or contaminants from the fluid in which they are contained by applying an electrical field (electrophoresis) to a sample of the fluid that is contained between our “restriction” membranes and flows through another membrane for separation.

Memphasys Limited 30-32 Richmond Road Homebush West NSW 2140

Postal Address Contact Details E info@memphasys.com P.O. Box 2202 P +612 8415 7300 W memphasys.com Homebush West NSW 2140 F +612 8415 7399 ABN 33 120 047 556